Preclinical study suggests ARID1a may be useful biomarker for immunotherapy – Medical Xpress
Medical XpressPreclinical study suggests ARID1a may be useful biomarker for immunotherapyMedical XpressTreatment with the checkpoint blockade therapy significantly improved survival in mice with ARID1a mutations, suggesting immunotherapy could be usefu… Continue reading
